AZD-5213

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAZD-5213
Drug Alias NameAZD-5213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsCognitive DysfunctionDiabetic NeuropathiesAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsCognitive DysfunctionDiabetic NeuropathiesAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A